Building Scalable, Reliable AAV Gene Therapy Manufacturing

Emmanuel Abate discusses how FDA's AMT designation and platform-based manufacturing can enhance the scalability and quality of AAV gene therapies.

Read More

Biodesign

Bioeconomy & Policy

Biomanufacturing & Scale-Up

Food & Agriculture

Aaron Blotnick

Food & Agriculture

Environment

Chemicals & Materials

Capital Markets

Biodesign

Aaron Blotnick

Biodesign

Bioeconomy & Policy

Biomanufacturing & Scale-Up

Food & Agriculture

Consumer Products

Jesse Daniel Brown

Biodesign

Bioeconomy & Policy

Biomanufacturing & Scale-Up

Food & Agriculture

Aaron Blotnick

Food & Agriculture

Environment

Chemicals & Materials

Capital Markets

Biodesign

Aaron Blotnick